The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• T-type calcium channels (Cav3.2) are crucial for transmitting pain signals.
• Dysregulation of these channels contributes to chronic pain conditions.

Purpose of the Study:

• To elucidate the regulatory mechanisms of Cav3.2 channels in nociception.
• To identify novel therapeutic targets for pain management.

Main Methods:

• Investigated the ubiquitination of Cav3.2 channels by WWP1.
• Identified USP5 as a deubiquitinating enzyme interacting with Cav3.2.
• Utilized shRNA and Tat peptides for in vivo knockdown and uncoupling experiments.
• Assessed channel activity and pain behaviors in mouse models.

Main Results:

• WWP1 ubiquitinates Cav3.2 channels at specific lysine residues.
• USP5 deubiquitinates Cav3.2, maintaining its protein levels and function.
• USP5 knockdown increases Cav3.2 ubiquitination, reduces protein levels, and diminishes channel currents.
• In vivo USP5 inhibition or uncoupling alleviates mechanical hypersensitivity in inflammatory and neuropathic pain models.

Conclusions:

• A novel signaling pathway involving WWP1 and USP5 regulates Cav3.2 channel activity.
• Targeting this pathway, specifically USP5, demonstrates therapeutic potential for managing pain.